Prime Medicine, Inc. (PRME) earnings
PRME earnings moved a median of -4.17% by the close. Quarterly and annual PRME reports and results, each read against the price at its own news timestamp. Back to the PRME overview →
22 measured PRME earnings events.
Where these PRME earnings landedvs 22 measured PRME earnings reactions
| Middle 50% of PRME earnings reactions | -7.80% to -2.51% |
|---|---|
| Median reaction (to close) | -4.17% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 PRME earnings events with a measured close landed between -7.80% and -2.51%; 9% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Prime Medicine, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.98% | -3.60% | |
| Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates | Press release | +0.98% | -3.60% | |
| Form 10-Q Prime Medicine, Inc. For: Mar 31 | SEC filing · Form 10-Q | +2.35% | -8.65% | |
| Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates | Press release | +2.35% | -8.65% | |
| Form 10-K Prime Medicine, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.90% | -5.16% | |
| CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | +1.17% | -0.91% | |
| Form 10-Q Prime Medicine, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.50% | -4.75% | |
| Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates | Press release | -1.50% | -4.75% | |
| Form 10-Q Prime Medicine, Inc. For: Jun 30 | SEC filing · Form 10-Q | +1.11% | -8.91% | |
| Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates | Press release | +1.11% | -8.91% | |
| Form 10-Q Prime Medicine, Inc. For: Mar 31 | SEC filing · Form 10-Q | -5.48% | -9.59% | |
| Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates | Press release | -5.48% | -9.59% | |
| Form 10-K Prime Medicine, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.08% | +4.56% | |
| Form 10-Q Prime Medicine, Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.84% | -1.74% | |
| Prime Medicine Reports Third Quarter 2024 Financial Results and Provides Business Updates | Press release | +4.84% | -1.74% | |
| Form 10-Q Prime Medicine, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.98% | -3.30% | |
| Prime Medicine Reports Second Quarter 2024 Financial Results and Provides Business Updates | Press release | -1.98% | -3.30% | |
| Form 10-Q Prime Medicine, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -5.24% | |
| Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates | Press release | +0.00% | -5.24% | |
| Form 10-K Prime Medicine, Inc. For: Dec 31 | SEC filing · Form 10-K | +2.12% | +0.34% | |
| Form 10-Q Prime Medicine, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.76% | -2.51% | |
| Prime Medicine Reports Third Quarter 2023 Financial Results and Provides Business Updates | Press release | -1.76% | -2.51% |
Keep exploring
More PRME: analyst actions → · SEC filings → · PRME overview →